CTOs on the Move

CurvaFix

www.curvafix.com

 
CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.curvafix.com
  • 1406 140th Place NE Suite 107
    Bellevue, WA USA 98007
  • Phone: 425.276.8800

Executives

Name Title Contact Details

Funding

CurvaFix raised $10.7M on 07/21/2020

Similar Companies

North Coast Medical Inc

North Coast Medical Inc is a Gilroy, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DCI International

DCI International is a Newberg, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bone Biologics

Bone Biologics was founded by University of California Los Angeles professors in collaboration with an Osaka University professor, and a USC surgeon in 2004. Formed to pursue regenerative medicine for bone, the company currently has as its strategic partners the Musculoskeletal Transplant Foundation, the nation's leading tissue bank and Orthofix, a leading global medical device company. Bone Biologics is currently focused on bone regeneration in spinal fusion using its recombinant human protein known as Nell-1. Nell-1 is an osteoinductive orthobiologic; a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone Biologics from UCLA.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.

Nucleus Medical Art Inc

Nucleus Medical Art Inc is a Kennesaw, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.